about
The clinical effectiveness and cost-effectiveness of ablative therapies in the management of liver metastases: systematic review and economic evaluationSystematic review and meta-analysis of immunohistochemical prognostic biomarkers in resected oesophageal adenocarcinomaSite and Stage of Colorectal Cancer Influence the Likelihood and Distribution of Disease Recurrence and Postrecurrence Survival: Data From the FACS Randomized Controlled Trial.Recognition of skin malignancy by general practitioners: observational study using data from a population-based randomised controlled trial.Surgery for colorectal liver metastases.Effectiveness of appropriately trained nurses in preoperative assessment: randomised controlled equivalence/non-inferiority trial.OncoSurge: a strategy for improving resectability with curative intent in metastatic colorectal cancer.Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial.Short- and long-term outcomes after laparoscopic and open hepatic resection: systematic review and meta-analysisCancer-associated fibroblasts predict poor outcome and promote periostin-dependent invasion in oesophageal adenocarcinoma.T cells but not NK cells are associated with a favourable outcome for resected colorectal liver metastases.Molecular profiling of the invasive tumor microenvironment in a 3-dimensional model of colorectal cancer cells and ex vivo fibroblastsStratifying risk of recurrence in stage II colorectal cancer using deregulated stromal and epithelial microRNAs.Adjuvant chemotherapy with gemcitabine and cisplatin compared to observation after curative intent resection of cholangiocarcinoma and muscle invasive gallbladder carcinoma (ACTICCA-1 trial) - a randomized, multidisciplinary, multinational phase IIIImpact of the introduction of fee for service payments on types of minor surgical procedures undertaken by general practitioners: observational study.The clinical and biological significance of MIR-224 expression in colorectal cancer metastasis.The diagnostic accuracy of a single CEA blood test in detecting colorectal cancer recurrence: Results from the FACS trialA randomised controlled trial to assess the cost-effectiveness of intensive versus no scheduled follow-up in patients who have undergone resection for colorectal cancer with curative intent.Tumour infiltrating lymphocytes correlate with improved survival in patients with oesophageal adenocarcinoma.FOXO3 expression during colorectal cancer progression: biomarker potential reflects a tumour suppressor role.MicroRNAs: key players in carcinogenesis and novel therapeutic targets.Authentication and characterisation of a new oesophageal adenocarcinoma cell line: MFD-1.Tumour-infiltrating lymphocytes predict for outcome in HPV-positive oropharyngeal cancer.The adaptive immune response to colorectal cancer: from the laboratory to clinical practice.Effect of 3 to 5 years of scheduled CEA and CT follow-up to detect recurrence of colorectal cancer: the FACS randomized clinical trial.Oncofetal fibronectin and oral squamous cell carcinoma.A top-down view of the tumor microenvironment: structure, cells and signaling.What carcinoembryonic antigen level should trigger further investigation during colorectal cancer follow-up? A systematic review and secondary analysis of a randomised controlled trial.Translational aspects in targeting the stromal tumour microenvironment: from bench to bedside.A minimum core outcome dataset for the reporting of preclinical chemotherapeutic drug studies: Lessons learned from multiple discordant methodologies in the setting of colorectal cancer.Propensity score-based analysis of outcomes of laparoscopic versus open liver resection for colorectal metastases.Patterns of progression, treatment of progressive disease and post-progression survival in the New EPOC study.A comparison of primary oesophageal squamous epithelial cells with HET-1A in organotypic culture.The desmoplastic reaction surrounding hepatic colorectal adenocarcinoma metastases aids tumor growth and survival via alphav integrin ligation.Natural killer cell maturation markers in the human liver and expansion of an NKG2C+KIR+ population.Guidelines for resection of colorectal cancer liver metastases.Laparoscopic right hepatectomy: a challenging, but feasible, safe and efficient procedure.Laparoscopic versus open left lateral hepatic sectionectomy: A comparative study.Short- and medium-term results of totally laparoscopic resection for colorectal liver metastases.miR-153 supports colorectal cancer progression via pleiotropic effects that enhance invasion and chemotherapeutic resistance.
P50
Q26852938-F02D785B-6A2E-40BF-9548-C25992E27968Q28085367-F0592F39-BF09-4802-85C8-2AC2E7C0711BQ30978235-97C01D43-D653-451A-8EA0-A8521E3421F7Q33398022-5F520DFA-329E-469B-A57A-D6D59F301C69Q33834452-C52E699A-FD2C-4722-A8CA-9D9C1A20CA85Q34390509-CE0B851B-B3B4-45E6-BFB3-5F427EAA85DCQ34455189-DC69F144-F27A-45E8-A5BD-4460353DACFDQ34656647-473D0004-612E-4906-9D87-7BB2CB78C3DCQ34978315-645B8610-D152-4274-A91B-CA2D99FC9FF5Q35035236-C13A1033-3861-4767-8D22-A8D06D55636DQ35119559-7D4A2CA9-A9F5-4417-9774-BE45332938ECQ35170178-EDE96546-19D0-45E5-9150-5BA8DF994AE2Q35580945-FCF5510C-FB80-4555-B7CA-7FB6794F37B4Q35728465-23CAFB64-D82A-4DDC-B17C-B391025AFC2AQ35904188-708C3E44-A008-4A63-99D7-4AFA0D2AC5BFQ36090214-91D2035C-3E25-4B33-A71D-4B8C0F558872Q36304168-4470E3BC-0036-4533-BBD4-6CA744E9EB07Q36412771-C36974D3-9C92-41D8-8DDF-531EA45CC546Q36936582-31EE3274-5419-4B82-8872-6A0C0ADE1A6FQ37040688-A5749373-1836-47ED-984D-BD819B010D5EQ37223100-E6653468-1A80-4304-8721-C6CEAF889584Q37236624-5D868E6C-18C6-4887-AE2B-C72800BC1253Q37507336-DBCE8B37-54C1-42EA-9EAF-54C5B752FEB7Q38020591-91170A36-CFE7-44FB-89C5-48302EB8FCA2Q38437654-55636BAC-7450-448D-8D17-39BCD220E59CQ38458640-C6E2265C-034F-471E-B4B4-5158771FADC9Q38527867-AF445CAA-DE7D-4920-A53B-63DCF8AF75F2Q38724626-5EEA8218-E060-418B-A6B8-FA7B2D3D535FQ38858806-49358624-144B-4D27-B72D-36C235A3ECBBQ39191297-8034D207-86A0-4F00-9365-43C143B6BC76Q39532367-7C594C22-896E-40AA-94DB-8D99C7E68C0AQ39585475-B075AF3F-0180-4159-847F-9638F16C7F0CQ39655711-4F4EB839-3964-46C2-BC4E-FFE88BE408A4Q39928463-DCF45EDE-E458-4920-A069-FFCBFCEB7906Q41030531-FE7C7665-17AD-4F57-AE49-192433AD97EBQ42150472-2A99892F-A5BA-4C31-859D-CF192E34E60EQ42613885-97D4EB69-E4AC-4C79-8FEE-62B127521F91Q42647160-F90F8CEF-3531-45D6-A5C9-38058E08CB54Q42660839-BD5FE0D8-AF2C-4546-968F-5EDC9F1CB99EQ42921031-EDD4494B-A36D-49E5-B847-F226557B01CF
P50
description
researcher
@en
researcher
@en-gb
wetenschapper
@nl
հետազոտող
@hy
name
John Primrose
@ast
John Primrose
@en
John Primrose
@en-gb
John Primrose
@es
John Primrose
@nl
John Primrose
@sl
type
label
John Primrose
@ast
John Primrose
@en
John Primrose
@en-gb
John Primrose
@es
John Primrose
@nl
John Primrose
@sl
prefLabel
John Primrose
@ast
John Primrose
@en
John Primrose
@en-gb
John Primrose
@es
John Primrose
@nl
John Primrose
@sl
P106
P1153
7005091532
P31
P496
0000-0002-2069-7605